Dendritic core compounds

US9828341B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9828341-B2
Application numberUS-201314646807-A
CountryUS
Kind codeB2
Filing dateNov 28, 2013
Priority dateNov 28, 2012
Publication dateNov 28, 2017
Grant dateNov 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to compounds that are useful for the preparation of dendrimer compounds, the use of these compounds for preparing dendrimers and processes for preparing the compounds.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) wherein: Y is O; B is O; R 1 and R 2 are absent; and either A, E, D and X are all CH 2 ; or A, D and X are all CH 2 and E is (CH 2 CH 2 O) t # CH 2 ; wherein # indicates a point of attachment of E to its adjacent carbonyl group; t is an integer from 1 to 10; or wherein: Y is C; R 1 and R 2 are both H; and A, E, B and D are CH 2 and X is O; or wherein: Y is C; X is O; B is (CH 2 ) p ; A, E and D are all CH 2 ; and R 1 is H, NHZ or C 1-6 alkyl and R 2 is a radical of formula (i) or a radical of formula (ii) Z is H, acyl, C(O)(CH 2 ) w N(H)G, *CH 3 *C(O)— where *C denotes 13 C or 14 C, 4-carboxytetramethylrhodamine, resorcinolphthalein, 7-amino-4-methyl-6-sulfocoumarin-3-acetic acid, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene or 1-{3-{[4-(2-cyclooctyn-1-ylmethyl)benzoyl]amino}propyl}-4-{2-[4-(dimethylamino)phenyl]ethenyl}pyridinium hexafluorophosphate; w is an integer from 1 to 11; G is H, acyl, t-butoxycarbonyl, 2,2,2-trichloroethyloxycarbonyl, 9-fluorenylmethoxycarbonyl, benzyloxycarbonyl,*CH 3 *CO— where *C denotes 13 C or 14 C, 4-carboxytetramethylrhodamine, resorcinolphthalein, 7-amino-4-methyl-6-sulfocoumarin-3-acetic acid, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene or 1-{3-{[4-(2-cyclooctyn-1-ylmethyl)benzoyl]amino}propyl}-4-{2-[4-(dimethylamino)phenyl]ethenyl}pyridinium hexafluorophosphate; or wherein: Y is C; X is O; B is (CH 2 ) p ; A, E and D are all CH 2 ; and R 1 and R 2 , both the same, are a radical of formula (i) or a radical of formula (ii) R 3 is a radical of formula (iii) or a radical of formula (iv) each T is independently selected from the group consisting of (CH 2 CH 2 O) x (CH 2 CH 2 and CH 2 ; each x is independently an integer from 1 to 12; m is an integer from 1 to 11, provided that when T is (CH 2 CH 2 O) x CH 2 CH 2 then m is 1; n is an integer from 1 to 11, provided that when T is (CH 2 CH 2 O) x CH 2 CH 2 then n is 1; p is an integer from 1 to 5; R 5 is H, and M is sodium or ammonium. 2. The compound of claim 1 wherein each T is CH 2 . 3. The compound of claim 1 wherein at least one T is (CH 2 CH 2 O) x CH 2 CH 2 . 4. The compound of claim 1 , wherein Y is C. 5. The compound of claim 1 , wherein R 3 is a radical of formula (iii) 6. The compound of claim 1 , wherein R 3 is a radical of formula (iv) 7. The compound of claim 1 , wherein R 1 and R 2 are both a radical of formula (i) or are both a radical of formula (ii) 8. The compound of claim 1 , herein R 5 is 9. The compound of claim 1 , wherein Y is C; R 1 and R 2 are both H; A, E, B and D are CH 2 and X is O. 10. The compound of claim 1 , wherein: Y is C; X is O; A, E and D are all CH 2 ; B is (CH 2 ) p ; R 1 is NHZ or C 1-6 alkyl; R 2 is a radical of formula (i) or a radical of formula (ii) Z is H, acyl, C(O)(CH 2 ) w NHG, *CH 3 *C(O)— where *C denotes 13 C or 14 C, 4-carboxytetramethylrhodamine; resorcinolphthalein, 7-amino-4-methyl-6-sulfocoumarin-3-acetic acid, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene or 1-{3-{[4-(2-cyclooctyn-1-ylmethyl)benzoyl]amino}propyl}-4-{2-[4-(dimethylamino)phenyl]ethenyl}pyridinium hexafluorophosphate; w is an integer from 1 to 11; and G is H, acyl, t-butoxycarbony 2,2,2-trichloroethyloxycarbonyl, 9-fluorenylmethoxycarbonyl, benzyloxycarbonyl, *CH 3 *CO— where *C denotes 13 C or 14 C, 4-carboxytetramethylrhodamine, resorcinolphthalein; 7-amino-4-methyl-6-sulfocoumarin-3-acetic acid, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene or 1-{3-{[4-(2-cyclooctyn-1-ylmethyl)benzoyl]amino}propyl}-4-{2-[4-(dimethylamino)phenyl]ethenyl}pyridinium hexafluorophosphate. 11. The compound of claim 1 , wherein Y is C; X is O; A, E and D are all CH 2 ; B is (CH 2 ) p ; R 1 and R 2 , both the same, are a radical of formula (i) R 3 is a radical of formula (iii) and p is 1. 12. The compound of claim 1 , wherein Y is C; Y is O; A, E and D are all CH 2 ; B is (CH 2 ) p ; R 1 and R 2 , both the same, are a radical of formula (ii) and R 3 is a radical of formula (iv) and p is 1. 13. The compound of claim 1 , wherein Y is C; R 1 and R 2 are both H; A, E, B and D are CH 2 ; X is O; and R 3 is a radical of formula (iii) 14. The compound of claim 1 , wherein Y is C; R 1 and R 2 are both H; A, E, B and D are CH 2 ; X is O; and R 3 is a radical of formula (iv) 15. The compound of claim 1 , wherein Y is C; Y is O; A, E and D are all CH 2 ; B is (CH 2 ) p ; R 1 is H; R 2 is a radical of formula (i) R 3 is a radical of formula (iii) and p is 1. 16. The compound of claim 1 , wherein Y is C; X is O; E and D are all CH 2 ; B is (CH 2 ) p ; R 1 is H; R 2 is a radical of formula (ii) R 3 is a radical of formula (iv) and p is 1. 17. The compound of claim 1 , wherein Y is C; X is O; A, E and D are all CH 2 ; B is (CH 2 ) p ; R 1 is H; R 2 is a radical of formula (ii) R 3 is a radical of formula (iii)

Assignees

Inventors

Classifications

  • having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated (peptides C07K) · CPC title

  • C07D207/46Primary

    with hetero atoms directly attached to the ring nitrogen atom · CPC title

  • having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms · CPC title

  • having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9828341B2 cover?
The invention relates to compounds that are useful for the preparation of dendrimer compounds, the use of these compounds for preparing dendrimers and processes for preparing the compounds.
Who is the assignee on this patent?
Victoria Link Ltd
What technology area does this patent fall under?
Primary CPC classification C07D207/46. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).